High‐Performance Liquid Chromatography Determination of Latanoprost in Pharmaceutical Formulations using UV Detection

Abstract

A simple, fast, and accurate high‐performance liquid chromatography (HPLC) method was developed to determine latanoprost in pharmaceutical formulations. The drug was chromatographed on a C₁₈ column. Eluents were monitored at a wavelength of 210 nm using a mixture of acetonitrile and 0.05 M potassium phosphate buffer pH 3.0 (70:30, (v/v). A linear response (r>0.9998) was observed in the range of 10.0–90.0 µg mL^?1. The method showed good recoveries (average 100.4%) and the relative standard deviations intra‐ and inter‐day were ≤1.0%. The method can be used for quality control assay of latanoprost in raw materials as well as in pharmaceutical formulations.     

A Kinetic spectrophotometric method for determination of amlodipine and Nifedipine in pharmaceutical preparations

A simple, accurate, sensitive and economical procedure for the estimation of amlodipine besylate and nifedipine, both in pure and dosage forms, has been developed. The method is based on the reduction of iron(III) by the studied drugs and subsequent interaction of iron(II) with ferricyanide to form Prussian blue. The reaction develops through a slow kinetics and completes in about 10 min. Both initial slope and fixed time methods were used to derive calibration graphs. The resulted calibration equations were linear in the concentration ranges of 1.0-20.0 and 3.0-19.0 μg ml^-1 for AML and NIF, and the detection limits were 0.10 and 0.19 μg ml^-1, respectively. Seven replicate analyses of solutions containing three different levels of each drug resulted in very low relative error of prediction (less than 1.6%) and relative standard deviation (less than 4%) confirming accuracy and precision of the proposed method. The proposed method was applied to the determination of these drugs in pharmaceutical formulations and excellent recoveries were obtained.     

Facile LC‐UV methods for simultaneous monitoring of ciprofloxacin and rosuvastatin in API,formulations and human serum

An efficient, selective and cost‐effective liquid chromatographic assay was developed and validated for the simultaneous quantification of ciprofloxacin and rosuvastatin in Active Pharmaceutical Ingredients (API), pharmaceutical formulations and in human serum. The chromatographic system consisted of mobile phase methanol–water, 90:10 v/v at pH 3.0 adjusted with o‐phosphoric acid, pumped at 1.0 mL/min through a prepacked Purospher Star C18 (5 µm, 25 × 0.46 cm) column and effluent was monitored at the isosbestic point (255 nm) as well as at the λ_max of individual drugs (243 and 271 nm). The method was validated over a linear concentration range of 0.25–15 µg/mL for ciprofloxacin and 0.33–20 µg/mL for rosuvastatin (r² ≥ 0.999). The ranges of reliable response (limits of detection and quantitation) for ciprofloxacin were 3–15 and 9–45 ng/mL and 17–29 and 52–88 ng/mL, respectively, for rosuvastatin in all API, pharmaceutical formulations and human serum. Analytical recovery from human serum was >98% and relative standard deviation (RSD) was <2. The accuracies were 97.13–102.55 and 97.41–101.31% and precisions in RSD were 0.04–1.90 and 0.02–1.23% for ciprofloxacin and rosuvastatin, respectively. No matrix interferences, ion suppression/enhancement and carry‐over were detected. The total assay run time was less than 5 min. In another study, for optimum performance the detector was programmed for multiwavelength scanning at the absorption maxima of each component. Consequently, the linearity range was improved and limit of detection and quantitation values were down to 1–4 and 4–12 ng/mL for ciprofloxacin and 3–5 and 9–15 ng/mL for rosuvastatin, respectively. The validation parameters fitted ICH guidelines through the isosbestic and individual λ_max approach. The small sample volume and simplicity of preparation make this method suitable for use in human serum samples, pharmaceutical formulations, quality control, drug–drug interaction studies, clinical laboratories, drug research centers and forensic medical centers. Copyright © 2014 John Wiley & Sons, Ltd.     

Potentiometric Response of Modified Carbon Paste Electrode Based on Mixed Ion‐Exchangers

A new chemically modified carbon paste electrode based on a mixture of two ion‐exchangers namely chlorpheniramine‐silicotungstate (CPM‐ST) and chlorpheniramine‐tetraphenylborate (CPM‐TPB) as ion‐exchange site for determination of chlorpheniramine maleate (CPM) was described. The best performance was exhibited by the electrode having the paste containing 3.0 wt% ion‐exchangers (CPM‐ST&CPM‐TPB), 48.5 wt% graphite, 47.5 wt% DOPh and 1.0 wt% NaTPB. The proposed chemically modified carbon paste electrode exhibited a Nernstian response for CPM over a wide concentration range of 1.2×10^?6 to 1.0×10^?2 M with a detection limit of 5.1×10^?7 M between pH 4.5 and 7.7 with fast response ≤10 s. The sensor showed good selectivity for CPM with respect to a large number of inorganic cations, organic cations, sugars, amino acids and some common drug excipients. The modified electrode was applied to potentiometric determination of CPM in its pharmaceutical preparations and biological fluids (serum and urine) with average recoveries of 97.5–102% and relative standard deviations of 0.32–1.97%.     

Novel Potentiometric Sensors for Determination of Melatonin and Oxomemazine in Biological Samples and in Pharmaceutical Formulations

Simple, selective and accurate sensors were developed for the determination of melatonin and oxomemazine in biological samples (urine) and in pharmaceutical preparations. Potentiometric measurements were based on bismus tetraiodate‐drug ion‐pair as novel electroactive materials incorporating a plasticized PVC membrane with o‐nitrophenyl octyl ether or dioctyl phthalate. Each sensor was conditioned for at least two days in 0.1 M drug solution before use. It exhibited fast and stable Nernstian response for melatonin and oxomemazine over the concentration range of 1.0×10^?6–1.0×10^?2 M and 1.0×10^?5–1.0×10^?2 M, pH range of 3.0–6.5 and 3.5–6.0 for melatonin and oxomemazine sensors, respectively. Results with an average recovery not more than 101 % and a mean standard deviation less than 1.0 % of the nominal were obtained for the four sensors. The sensors showed reasonable selectivity towards investigated drugs in presence of many cations.     

Simultaneous Determination of Dipyrone and Papaverine in Pharmaceutical Formulation using PLS Regression and UV Spectrophotometry

Abstract

A combination of sodium dipyrone and papaverine hydrochloride is used as an analgesic and antispasmodic drug. A simple and rapid procedure is proposed for simultaneous determination of these drugs in commercial formulations (Melpaz^®) based on partial least squares (PLS) regression and UV spectrophotometric measurements in the range of 218–300 nm. The calibration set was built with 25 solutions in concentrations ranging from 15.0–35.0 mg ml^?1 for dipyrone and from 0.5–1.5 mg ml^?1 for papaverine in methanol. The relative standard deviation (RSD) was 1.05% for dipyrone and 1.55% for papaverine in pharmaceutical formulations. The percent of relative recovery was 95.9% for dipyrone and 95.2% for papaverine. Figures of merit, such as accuracy, precision, sensitivity and adjust were also determined. The methodology was validated by using an independent method, based on high performance liquid chromatography (HPLC).     

High-performance column liquid chromatographic method for the simultaneous determination of buclizine, tryptophan, pyridoxine, and cyanocobalamin in tablets and oral suspension

An HPLC method was developed and validated for the simultaneous determination of buclizine, tryptophan, pyridoxine, and cyanocobalamin in pharmaceutical formulations. The chromatographic separation was carried out on an RP-C18 column using a mobile phase gradient of methanol, 0.015 M phosphate buffer (pH 3.0), and 0.03 M phosphoric acid at a flow rate of 1.0 mL/min and UV detection at 230, 280, and 360 nm, respectively, for buclizine, tryptophan, pyridoxine, and cyanocobalamin. The method validation yielded good results with respect to linearity (r>0.999), specificity, precision, accuracy, and robustness. The RSD values for intraday and interday precision were below 1.82 and 0.63%, respectively, and recoveries ranged from 98.11 to 101.95%. The method was successfully applied for the QC analysis of buclizine, tryptophan, pyridoxine, and cyanocobalamin in tablets and oral suspension.     

Electrochemical reduction of ciprofloxacin at the mercury electrode and its voltammetric determination in tablet and urine

In this study a reduction square wave voltammetric method was developed and validated for the direct determination of ciprofloxacin (CIP) in pharmaceutical formulation and biological fluid using hanging mercury dropping electrode (HMDE) surface. Best results were obtained for the quantitative determination of CIP in 0.02 M Britton-Robinson buffer at pH 2.5 and at a potential of ?1300 mV vs. Ag/AgCl reference electrode. Various experimental and instrumental parameters affecting the peak current and potential of CIP electrochemical reduction were investigated and optimized. The monitored peak current was directly proportional to the concentration of CIP, where it exhibited a linear response in the range 3.0 × 10^?7–2 × 10^?6 M (r = 0.99). The accuracy of the proposed method was concluded based on the value of mean recovery of 98 ± 0.72 % with RSD of 0.181 % at a detection limit of 7 × 10^?9 M. Possible interferences by various substances usually present in pharmaceutical formulations have been also evaluated. After validating the proposed method, the applicability of this voltammetric method was demonstrated by estimating CIP in its pharmaceutical formulation and spiked human urine, where values of mean recoveries of 97 ± 1.0% and 108.0 ± 2.0% were obtained, respectively.     

Optimizing the extraction, separation and quantification of tricyclic antidepressant drugs in human plasma with CE-ESI-TOF-MS using cationic-coated capillaries

In this study, the extraction and CE-ESI-TOF-MS analysis of tricyclic antidepressant (TCA) drugs imipramine, desipramine, clomipramine and norclomipramine in human plasma has been optimized. The CE capillaries were modified with ω-iodo-alkyl ammonium salt (M7C4I coating) to reduce analyte adsorption to the silica wall. The use of a strong cation exchange (SCX) solid-phase extraction (SPE) column specifically designed for the extraction of basic drug species from biofluids gave very clean extracts with high and reproducible recoveries. The extraction recoveries were ranging between 87 and 91% with % RSD values of 0.5-1.7% (n=3). The obtained strong cation exchange-SPE extracts of the TCA in human plasma only contained the analytes of interest. The optimized CE separation conditions were obtained by adding ACN and acetic acid to the sample while using an aqueous BGE. The CE-ESI-TOF-MS analysis was performed within 6 min for all TCA analytes under the optimized condition with peak efficiencies up to 1.4 x 10? plates/m and an average % RSD of the migration times of the analytes of 0.3% (n=5). The presented method can readily be used for the extraction and quantification of basic drug species in human biological fluids and in pharmaceutical formulations.     

Effect of Different Pretreatment Methods on the Measurement of the Entrapment Efficiency of Liposomes and Countermeasures in Free Drug Analysis

Further investigation into the methods for the analysis of the entrapment efficiency of liposomes has been prompted by the urgent need to improve traditional methods which offer more risk to liposome leakage. The aim of this study was to investigate the suitability of hollow fiber centrifugal ultrafiltration (HF-CF-UF) coupled with HPLC as an alternative method for the routine determination of the entrapment efficiency of liposomes and to compare it with previously developed nonequilibrium procedures based on size-exclusion chromatography (SEC). By comparison, evaluation of the entrapped fraction with SEC resulted in 3 or 4 % lower entrapment values. More importantly, the free drug concentrations were three- to sixfold higher than with HF-CF-UF. In addition, we investigated the reasons for the different values obtained with SEC and a dynamic equilibrium theory was put forward based on this. In addition, we have developed and characterized an equilibrium method of separating free and liposomal drugs for liposomal formulations based on HF-CF-UF. The method was validated over the concentration range of 7.9–235 μg mL^?1 for indomethacin and 0.258–8.24 μg mL^?1 for vitamin A. Inter- and intra-day precision (RSD %) were ≤1.2 % for indomethacin and ≤1.8 % for vitamin A, respectively. The recoveries of both free drug and total drug were higher than 96.0 % with RSD ≤1.3 % (n = 5). Taken together, our improved method differs from those previously reported with regard to higher recovery, small sample volume, less laborious, and most importantly without damaging or disturbing liposomes. Validation results suggested that our method was sufficiently accurate and sensitive to be used to evaluate the entrapment efficiency of a liposome formulation without complicated pretreatment.     

Gas-Liquid Chromatographic Determination of Diphenhydramine (Dimedrol) Hydrochloride in Some Pharmaceutical Formulations

Abstract

A rapid quantitative gas-liquid chromatographic procedure for the determination of 2-diphenylmethoxy-N, N-dimethylethanamine (diphenhydramine, dimedrol) hydrochloride, in pure form and when it is dispensed in eye drops and lotion, is described. The antihistaminic drug requires no conversion to the free base, and the assayed pharmaceutical formulations need no sample cleanup, preliminary drug separation or derivatization. The method is adopted for a concentration range varied between1.0 - 10 mg.ml^?1 of the drug in ethanolic solutions. The accuracy obtained was 98.6 ± 0.31%, 93.3 ± 0.82%, and 87.9 ± 1.1% for the authentic diphenhydramine hydrochloride, its eye drops and its lotion. The 50% - addition of the drug to the labelled claim in the galenical forms, eye drops and lotion, gives average mean recoveries of 100.8 ± 0.74% and 97.9 ± 0.45% respectively.     

A New Approach for Decreasing the Detection Limit of Gentamicin Ion‐selective Electrodes by Incorporation of Multiwall Carbon Nanotubes (MWCNTs)/Lipophilic Anionic Additives

Two novel carbon paste electrodes based on gentamicin‐reineckate (GNS‐RN)/multiwall carbon nanotubes (MWCNTs)/sodium tetraphenyl borate (NaTPB) or potassium tetraphenylborate (KTPB) for potentiometric determination of gentamicin sulfate were constructed. Our endeavors of lowering the detection limit for gentamicin ion‐selective electrodes were described. The paper focused on gentamicin carbon paste electrodes based on GNS‐RN as electroactive material, o ‐nitrophenyloctyl ether (o ‐NPOE) as plasticizer and incorporation of MWCNTs and lipophilic anionic additives (NaTPB and KTPB) which lower the detection limit of the electrodes showing best results for determination of gentamicin ion. The characteristics of the electrodes, GNS‐RN+NaTPB+MWCNTs (sensor 1) and GNS‐RN+KTPB+ MWCNTs (sensor 2), were measured, showing favorable features as they provided measurements of the potential with near‐Nernstian slopes of 29.6±0.3 and 29.1±0.3 mV/decade over the concentration range of 1.0×10⁻⁶–1.0×10⁻² mol L⁻¹ and pH ranges 3.0–8.2 and 3.0–8.0 in short response times (6.5 sec). Importantly, the electrodes had low detection limits of 3.0×10⁻⁷and 3.4×10⁻⁷ mol L⁻¹ for the two sensors, respectively. The sensors showed high selectivity for gentamicin ion with respect to a large number of interfering species. The electrodes were successfully applied for the potentiometric determination of GNS ions in pure state, pharmaceutical preparations and human urine with high accuracy and precision. The results of this study were compared with some previously published data using other analytical methods.     

Spectrophotometric determination of clotrimazole and Phenylephrine-HCl in pharmaceutical formulation using 1, 2-naphthoquinone-4-Sulphonic acid sodium salt (NQS) as a chromogenic reagent

A sensitive, rapid and economical spectrophotometric method based on their interaction with NQS reagent in basic medium, which produces orange-colored complexes, has been devised to identify many drugs with amino groups (clotrimazole and phenylephrine-HCl). The maximum absorption for the complexes of clotrimazole and phenylephrine-HCl is 455 and 484 nm, respectively. Beer's law is applicable in the concentration ranges of (2–40) μg/ml for clotrimazole and (0–20) μg/ml for phenylephrine-HCl. The molar absorptivity values are 3931.1760 L/mol.cm and 4521.4074 L/mol.cm of clotrimazole and phenylephrine-HCl respectively with accuracy of 100.0285%–103.1456% and RSD better than 3.3211%. The method has been successfully used to determine these medications in pharmaceutical formulations, and it has been found to be superior to British Pharmacopeia standard procedures. At a 95% confidence level, F and t-tests are less than the tabulated values.     

Quinalizarin anchored on Amberlite XAD-2. A new matrix for solid-phase extraction of metal ions for flame atomic absorption spectrometric determination

Amberlite XAD-2 has been functionalized by coupling it to quinalizarin [1,2,5,8-tetrahydroxyanthraquinone] by means of an -N = N- spacer. Elemental analysis, thermogravimetric analysis, and infrared spectra were used to characterize the resulting new polymer matrix. The matrix has been used to preconcentrate Cu(II), Cd(II), Co(II), Pb(II), Zn(II), and Mn(II) before their determination by flame atomic absorption spectrometry (FAAS). UO₂(II) has been preconcentrated for fluorimetric determination. The optimum pH values for maximum adsorption of the metals are between 5.0 and 7.0. All these metal ions are desorbed (recovery 91–99%) with 4 mol L^–1 HNO₃. The adsorptive capacity of the resin was found to be in the range 0.94–5.28 mg metal g^–1 resin and loading half-life (t_1/2) between 5.3 and 15.0 min. The effects of NaF, NaCl, NaNO₃, Na₂SO₄, Na₃PO₄, Ca(II), and Mg(II) on the adsorption of these metal ions (0.2 μg mL^–1) are reported. The lower limits of detection for these metal ions are between 1 and 15.0 μg L^–1. After enrichment on this matrix flame AAS has been used to determine these metal ions (except the uranyl ion) in river water samples (RSD ≤ 6.5%); fluorimetry was used to determine uranyl ion in well water samples (RSD ≤ 6.3%). Cobalt from pharmaceutical vitamin tablets was preconcentrated by use of this chelating resin and estimated by FAAS (RSD ～ 4%).     

The application of quantitative NMR for the facile,rapid and reliable determination of clindamycin phosphate in a conventional tablet formulation

Spectroscopic tools such as NMR can be applied to the quantitative analysis of active pharmaceutical ingredients with relative ease and accuracy. Here, we demonstrate the quantification of clindamycin phosphate (CLP) in a conventional tablet formulation, performed using potassium hydrogen phthalate (KHP) as the internal standard and deuterium oxide (D₂O) as the NMR solvent. The methyl protons signal of CLP at 0.72 ppm (triplet) relative to the signal of KHP at 7.37–7.40 ppm (multiplet) was used for quantification purposes using ¹H NMR. This method was shown to be specific and linear (r = 0.9997) within the CLP concentration range from 7.2 to 23.1 mg per 0.5 ml of D₂O. The maximum relative standard deviation (RSD) of accuracy and precision was calculated at 0.39% and 0.64%, respectively. The limits of detection (LOD) and quantification were 0.04 and 0.11 mg/ml, respectively. The method was highly stable with a calculated RSD of 0.03%. The robustness of the method was demonstrated by changing four different parameters, and the difference among each parameter was ≤ 0.78%. The findings of this work were in good agreement with previously reported conventional HPLC‐based approaches, highlighting its applicability in the determination of other active pharmaceutical ingredients in conventional formulations for quality control purposes. Copyright © 2014 John Wiley & Sons, Ltd.     

Application of polyaniline–multiwalled carbon nanotubes composite fiber for determination of benzaldehyde in injectable pharmaceutical formulations by solid-phase microextraction GC–FID using experimental design

A polyaniline–multiwalled carbon nanotubes composite fiber was electrodeposited onto a platinum wire using cyclic voltammetry. This fiber was used for headspace solid-phase microextraction combined with gas chromatography and flame ionization detector of trace levels of benzaldehyde in some injectable pharmaceutical formulations. Three solid-phase microextraction parameters including temperature, time and stirring rate were investigated simultaneously using a three-level-three-factor Box–Behnken as experimental design on the extraction capability. The as-made fiber has a lifetime of over 300 extractions without any obvious decline in extraction efficiency. At the optimum conditions (extraction temperature 60°C, extraction time 15 min, stirring rate 700 rpm), the method displays excellent linearity over the concentration range of 25–1000 ng/mL of benzaldehyde with RSD values ranging from 1.0 to 6.8%. The limits of quantitation and detection were 25 and 10 ng/mL, respectively.     

Quantitative determinations of levofloxacin and rifampicin in pharmaceutical and urine samples using nuclear magnetic resonance spectroscopy

Rapid, specific and simple methods for determining levofloxacin and rifampicin antibiotic drugs in pharmaceutical and human urine samples were developed. The methods are based on (1)H NMR spectroscopy using maleic acid as an internal standard and DMSO-d6 as NMR solvent. Integration of NMR signals at 8.9 and 8.2 ppm were, respectively, used for calculating the concentration of levofloxacin and rifampicin drugs per unit dose. Maleic acid signal at 6.2 ppm was used as the reference signal. Recoveries of (97.0-99.4)+/-0.5 and (98.3-99.7)+/-1.08% were obtained for pure levofloxacin and rifampicin, respectively. Corresponding recoveries of 98.5-100.3 and 96.8-100.0 were, respectively, obtained in pharmaceutical capsules and urine samples. Relative standard deviations (R.S.D.) values < or =2.7 were obtained for analyzed drugs in pure, pharmaceutical and urine samples. Statistical Student's t-test gave t-values < or =2.87 indicating insignificant difference between the real and the experimental values at the 95% confidence level. F-test revealed insignificant difference in precisions between the developed NMR methods and each of fluorimetric and HPLC methods for analyzing levofloxacin and rifampicin.     

Direct Kinetic Determination of Bromhexine Hydrochloride in Pharmaceutical Formulations

Abstract

A very simple, automatic, fast method for the photometric determination of bromhexine hydrochloride based on the application of kinetic methodology and the stopped-flow mixing technique to the coupling reaction between the diazotized bromhexine derivative and N-(1-naphthyl)ethylenediamine is proposed. The high initial rate of this reaction allows analytical measurements to be made within only 0.5–1 s, which makes the method applicable to automatic routine analyses. The calibration graph is linear over the range 1.5–65.0 μg mL^?1 and the precision (as %RSD) is less than 2%. The presence of antibiotics such as penicillins and cephalosporins in a 100-fold excess has no effect on the analyte determination. The proposed method was satisfactorily used for direct analysis of pharmaceutical formulations containing these antibiotics.     

Simultaneous determination of 10 kinds of biogenic amines in rat plasma using high‐performance liquid chromatography coupled with fluorescence detection

We describe a simple, rapid, selective and sensitive HPLC method coupled with fluorescence detection for simultaneous determination of 10 kinds of biogenic amines (BAs: tryptamine, 2‐phenethylamine, putrescine, cadaverine, histamine, 5‐hydroxytryptamine, tyramine, spermidine, dopamine and spermine). BAs and IS were derivated with dansyl chloride. Fluorescence detection (λ_ex/λ_em = 340/510 nm) was used. A satisfactory result for method validation was obtained. The assay was shown to be linear over the ranges 0.005–1.0 μg/mL for tryptamine, 2‐phenethylamine and spermidine, 0.025–1.0 μg/mL for putrescine, 0.001–1.0 μg/mL for cadaverine, 0.25–20 μg/mL for histamine, 0.25–10 μg/mL for 5–hydroxytryptamine and dopamine, and 0.01–1.0 μg/mL for tyramine and spermine. The limits of detection and the limits of quantification were 0.3–75.0 ng/mL and 1.0–250.0 ng/mL, respectively. Relative standard deviations were ≤5.14% for intra‐day and ≤6.58% for inter‐day precision. The recoveries of BAs ranged from 79.11 to 114.26% after spiking standard solutions of BAs into a sample at three levels. Seven kinds of BAs were found in rat plasma, and the mean values of tryptamine, 2‐phenethylamine, putrescine, cadaverine, histamine, spermidine and spermine determined were 52.72 ± 7.34, 11.45 ± 1.56, 162.56 ± 6.26, 312.75 ± 18.11, 1306.50 ± 116.16, 273.89 ± 26.41 and 41.51 ± 2.07 ng/mL, respectively.     

A Validated Stability Indicating LC Method for Mitotane in Bulk Drugs and Pharmaceutical Dosage Forms

A novel, sensitive, stability indicating RP-LC method has been developed for the quantitative determination of mitotane, its impurity in both bulk drugs and pharmaceutical dosage forms. Efficient chromatographic separation was achieved using a C18 stationary phase with simple mobile phase combination delivered in an isocratic mode and quantitation was by ultraviolet detection at a wavelength of 230 nm. The mobile phase consisted of buffer and acetonitrile (25:75, v/v) delivered at a flow rate of 1.0 mL min^?1. Buffer consisted of 10 mM potassium dihydrogen orthophosphate monohydrate, pH adjusted to 2.5 by orthophosphoric acid. In the developed LC method the resolution (R _s ) between mitotane and its impurity namely Imp-1 was found to be greater than 2.5. Regression analysis shows an r value (correlation coefficient) greater than 0.999 for mitotane and its impurity. This method was capable to detect the impurity of mitotane at a level of 0.003% with respect to test a concentration of 0.2 mg mL^?1 for a 10 μL injection volume. The inter- and intra-day precision values for mitotane and its impurity was found to be within 2.0% RSD. The method has shown good and consistent recoveries for mitotane in bulk drugs (99.2–101.5%), pharmaceutical dosage forms (98.2–103.1%) and for its impurity (99.7–102.1%). The test solution was found to be stable in diluent for 48 h. The drug was subjected to stress conditions of hydrolysis, oxidation, photolysis and thermal degradation. Considerable degradation was found to occur in basic stress hydrolysis. The stress samples were assayed against a qualified reference standard and the mass balance was found close to 99.97%. The developed RP-LC method was validated with respect to linearity, accuracy, precision and robustness.